SCHEMBL4970977

SCHEMBL4970977

CCN(CC)C1Cc2cc(C)cc(-c3ccccc3Cl)c2O1

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.37
HTR7 P34969 4/20 0.37
AQP1 P29972 3/20 0.34
PLA2G7 Q13093 1/20 0.31
CDK1 P06493 1/20 0.31
CCNB1 P14635 1/20 0.31
PARP1 P09874 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
MEN1 O00255 1/20 0.30
HSP90AA1 P07900 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4828783 0.88 SIRT2 (0.32) HTR7ALDH1A1
SCHEMBL5140412 0.87 AQP1 (0.37) AQP1MEN1HSP90AA1KMT2A
SCHEMBL4710394 0.79 CNR1 (0.38) HTR1AHTR7AQP1PLA2G7PARP1
SCHEMBL4596402 0.78 PLA2G7 (0.35) HTR1AHTR7AQP1PLA2G7PARP1
SCHEMBL4226327 0.78 AQP1 (0.55) HTR1AHTR7AQP1PLA2G7PARP1
SCHEMBL4791170 0.78 AQP1 (0.39) AQP1ALDH1A1MAPTMEN1HSP90AA1
SCHEMBL4863731 0.76 NUDT1 (0.39) AQP1
SCHEMBL4235651 0.76 AQP1 (0.45) HTR1AHTR7AQP1PLA2G7ALDH1A1
SCHEMBL4235648 0.76 AQP1 (0.60) AQP1PLA2G7PARP1MAPT
SCHEMBL4790587 0.74 AQP1 (0.63) HTR1AHTR7AQP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879569-A2 THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS Wyeth (US) 2008-01-23 EP disclosed
WO-2006116221-A2 THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS WYETH (US) 2006-11-02 WO disclosed